Share on LinkedInShare on LinkedIn

ARTICLE · 02 MAY 2025

Federal Circuit Vacates Non-Infringement Judgment Over Improper Claim Construction

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Contributor
Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP is one of the world’s largest firms focusing on...

View firm profile
Explore more from Finnegan, Henderson, Farabow, Garrett & Dunner LLP

In Maquet Cardiovascular LLC v. Abiomed Inc., No. 2023-2045 (Fed. Cir. Mar. 21, 2025), the Federal Circuit vacated a judgment of non-infringement regarding Maquet's U.S. Patent...

United StatesIntellectual Property

In Maquet Cardiovascular LLC v. Abiomed Inc., No. 2023-2045 (Fed. Cir. Mar. 21, 2025), the Federal Circuit vacated a judgment of non-infringement regarding Maquet's U.S. Patent No. 10,238,783, ruling that the district court improperly narrowed the claim scope by misapplying prosecution disclaimer.

Marquet asserted that Abiomed infringed certain claims of the '783 patent directed to a system for deploying a blood pump to a desired location in a patient's circulatory system. At issue on appeal were the district court's claim construction rulings related to three terms in the '783 patent. The district court accepted Abiomed's arguments that prosecution history from prior applications required reading negative limitations into the claims—namely, that the claimed “guide mechanism comprising a lumen” does not encompass a lumen that is distal to a cannula or that passes through the pump's rotor blades.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from